Federal officials may remove warnings on testosterone therapy drugs about heart and prostate risks, which could expand access ...
Learn why the FDA is asking to update testosterone replacement therapy labels after a major review of new evidence.
Signs and symptoms of low testosterone are often very generalizable and can be due to something else, either in addition to ...
Morning Overview on MSN
Low testosterone in older men was tied to a leading cause of vision loss
Older men whose testosterone levels drop or are medically suppressed face a measurably higher risk of age-related macular ...
Most men assume that if their testosterone is low, they can get treatment. But since 2015, FDA labeling has included cautionary language noting that the safety and effectiveness of testosterone ...
After years of research, we finally understand how GLP-1s impact T on day 1 versus years later.
Second, the changes would ease longstanding warnings about the use of the hormone therapy in those with prostate cancer. Current labels say testosterone should not be used in men ...
The US Department of Health and Human Services is requesting revisions to the labels on testosterone replacement therapies for men after reviewing new data and evidence on their safety and benefits.
The Trump administration has moved to strip decades-old safety warnings from testosterone therapy labels, clearing a path for ...
Drs Chris and Xand ask - what are the pros and cons of testosterone replacement therapy?
A boxed warning for testosterone on major adverse cardiovascular events is out and a new blood pressure warning is in, the FDA announced late last week as part of a class-wide labeling update for all ...
June 18 (Reuters) - The U.S. health department said on Thursday it was seeking updates to labels for testosterone replacement therapies after reviewing new clinical data and other evidence. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results